Literature DB >> 23496404

Determining research priorities for clinician-initiated trials in infectious diseases.

David L Paterson1.   

Abstract

OBJECTIVES: To determine research priorities of infectious diseases physicians for clinician-initiated randomised controlled trials (RCTs). DESIGN, SETTING AND PARTICIPANTS: Online survey of infectious diseases physicians in Australia and New Zealand. MAIN OUTCOME MEASURES: Research priorities for, and perceived barriers to, clinician-initiated RCTs.
RESULTS: 122/550 infectious diseases physicians (22%) responded to the survey. The five highest ranked proposals for clinician-initiated RCTs were in the areas of prosthetic joint infections, septic arthritis and osteomyelitis of native joints, Staphylococcus aureus bloodstream infections, diabetic foot infections and the treatment of serious multiresistant, gram-negative bacterial infections. Lack of funding was the most important perceived barrier to participation in clinician-initiated RCTs.
CONCLUSIONS: The research focus of infectious diseases physicians - optimal treatment of commonly encountered serious infections - highlights a lack of well conducted RCTs in this area.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23496404     DOI: 10.5694/mja12.11703

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  5 in total

1.  Past, present and future of respiratory research: A survey of Canadian health care professionals.

Authors:  Mika Laura Nonoyama; Sunita Mathur; Rosemary Herbert; Heather Jenkins; Michelle Lobchuk; Michelle McEvoy
Journal:  Can Respir J       Date:  2015 Sep-Oct       Impact factor: 2.409

2.  A comparison of different antibiotic regimens for the treatment of infective endocarditis.

Authors:  Arturo J Martí-Carvajal; Mark Dayer; Lucieni O Conterno; Alejandro G Gonzalez Garay; Cristina Elena Martí-Amarista
Journal:  Cochrane Database Syst Rev       Date:  2020-05-14

3.  Meropenem versus piperacillin-tazobactam for definitive treatment of bloodstream infections due to ceftriaxone non-susceptible Escherichia coli and Klebsiella spp (the MERINO trial): study protocol for a randomised controlled trial.

Authors:  Patrick N A Harris; Anton Y Peleg; Jon Iredell; Paul R Ingram; Spiros Miyakis; Andrew J Stewardson; Benjamin A Rogers; Emma S McBryde; Jason A Roberts; Jeff Lipman; Eugene Athan; Sanjoy K Paul; Peter Baker; Tiffany Harris-Brown; David L Paterson
Journal:  Trials       Date:  2015-01-27       Impact factor: 2.279

4.  Managing diabetic foot infections: a survey of Australasian infectious diseases clinicians.

Authors:  Robert J Commons; Edward Raby; Eugene Athan; Hasan Bhally; Sharon Chen; Stephen Guy; Paul R Ingram; Katy Lai; Chris Lemoh; Lyn-Li Lim; Laurens Manning; Spiros Miyakis; Mary O'Reilly; Adam Roberts; Marjoree Sehu; Adrienne Torda; Mauro Vicaretti; Peter A Lazzarini
Journal:  J Foot Ankle Res       Date:  2018-04-10       Impact factor: 2.303

5.  Intermittent Negative Blood Cultures in Staphylococcus aureus Bacteremia; a Retrospective Study of 1071 Episodes.

Authors:  James D Stewart; Maryza Graham; Despina Kotsanas; Ian Woolley; Tony M Korman
Journal:  Open Forum Infect Dis       Date:  2019-11-18       Impact factor: 3.835

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.